Prevalence of overt and subclinical thyroid dysfunction in pregnant women and outcome in a tertiary care centre

Lakshmi Aravelli, Amritha Aurora Meduri, Swathi Rallabhandi, Kundena Srilakshmi
{"title":"Prevalence of overt and subclinical thyroid dysfunction in pregnant women and outcome in a tertiary care centre","authors":"Lakshmi Aravelli, Amritha Aurora Meduri, Swathi Rallabhandi, Kundena Srilakshmi","doi":"10.15587/2519-4798.2022.265721","DOIUrl":null,"url":null,"abstract":"Aim: To know the prevalence of overt and subclinical thyroid disorders in Indian pregnant women and to know the effect of overt and subclinical thyroid dysfunction on maternal and fetal outcome. \nMaterials and methods: This study was conducted at the Government Maternity Hospital, sultan bazaar, Osmania medical college, Hyderabad over a period of 15 months from august 2016 to October 2017. 1000 pregnant women who attended the antenatal clinic were screened for the thyroid dysfunction. Serum TSH level estimated. fT3, fT4 and anti TPO Ab levels were estimated if the TSH level was abnormal. Patients were managed accordingly and followed till the delivery. Maternal and fetal outcome recorded. \nResults: It was a prospective study done on 1000 antenatal women. Prevalence of thyroid disorder in this study was 11.3%. Prevalence of subclinical, overt hypothyroidism, subclinical and overt hyperthyroidism was 9.4%, 1.4%, 0.4% and 0.1% respectively. Subclinical hypothyroidism was associated with complications like preeclampsia (13.8%), Anaemia (15.95%), preterm delivery (6.38%), Intrauterine growth restriction (4.25%), low birth weight (12.76%) and Intrauterine fetal death)(2.12%). Overt hypothyroidism was associated with complications like Preeclampsia (14.28%), anaemia (21.4%), Preterm delivery (14.28%), intrauterine growth restriction (14.28%), low birth weight (21.4%) and Intrauterine fetal death (7.14%). Incidence of CD was 18.05% in women with hypothyroidism. Subclinical hyperthyroidism was associated with complications like Preeclampsia, Preterm delivery, Intrauterine growth restriction, Intrauterine fetal death. \nConclusion: Thyroid disorders in pregnancy are significantly associated with both maternal and fetal complications and adversely affect the outcome of pregnancy. Hence, early identification of thyroid disorders and timely initiation of treatment is essential","PeriodicalId":21672,"journal":{"name":"ScienceRise: Medical Science","volume":"37 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ScienceRise: Medical Science","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15587/2519-4798.2022.265721","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Aim: To know the prevalence of overt and subclinical thyroid disorders in Indian pregnant women and to know the effect of overt and subclinical thyroid dysfunction on maternal and fetal outcome. Materials and methods: This study was conducted at the Government Maternity Hospital, sultan bazaar, Osmania medical college, Hyderabad over a period of 15 months from august 2016 to October 2017. 1000 pregnant women who attended the antenatal clinic were screened for the thyroid dysfunction. Serum TSH level estimated. fT3, fT4 and anti TPO Ab levels were estimated if the TSH level was abnormal. Patients were managed accordingly and followed till the delivery. Maternal and fetal outcome recorded. Results: It was a prospective study done on 1000 antenatal women. Prevalence of thyroid disorder in this study was 11.3%. Prevalence of subclinical, overt hypothyroidism, subclinical and overt hyperthyroidism was 9.4%, 1.4%, 0.4% and 0.1% respectively. Subclinical hypothyroidism was associated with complications like preeclampsia (13.8%), Anaemia (15.95%), preterm delivery (6.38%), Intrauterine growth restriction (4.25%), low birth weight (12.76%) and Intrauterine fetal death)(2.12%). Overt hypothyroidism was associated with complications like Preeclampsia (14.28%), anaemia (21.4%), Preterm delivery (14.28%), intrauterine growth restriction (14.28%), low birth weight (21.4%) and Intrauterine fetal death (7.14%). Incidence of CD was 18.05% in women with hypothyroidism. Subclinical hyperthyroidism was associated with complications like Preeclampsia, Preterm delivery, Intrauterine growth restriction, Intrauterine fetal death. Conclusion: Thyroid disorders in pregnancy are significantly associated with both maternal and fetal complications and adversely affect the outcome of pregnancy. Hence, early identification of thyroid disorders and timely initiation of treatment is essential
妊娠妇女显性和亚临床甲状腺功能障碍的患病率和三级保健中心的结果
目的:了解印度孕妇显性和亚临床甲状腺功能障碍的患病率,了解显性和亚临床甲状腺功能障碍对母胎结局的影响。材料和方法:本研究于2016年8月至2017年10月在海得拉巴Osmania医学院苏丹巴扎政府妇产医院进行,为期15个月。1000名到产前诊所就诊的孕妇接受了甲状腺功能障碍筛查。估计血清TSH水平。如果TSH水平异常,则估计fT3、fT4和抗TPO Ab水平。对患者进行相应的管理和随访,直至分娩。记录母胎结局。结果:这是一项对1000名产前妇女进行的前瞻性研究。本研究中甲状腺疾病的患病率为11.3%。亚临床、显性甲状腺功能减退、亚临床和显性甲状腺功能亢进的患病率分别为9.4%、1.4%、0.4%和0.1%。亚临床甲状腺功能减退与子痫前期(13.8%)、贫血(15.95%)、早产(6.38%)、宫内生长受限(4.25%)、低出生体重(12.76%)和宫内死胎(2.12%)等并发症相关。明显的甲状腺功能减退与子痫前期(14.28%)、贫血(21.4%)、早产(14.28%)、宫内生长受限(14.28%)、低出生体重(21.4%)和宫内死胎(7.14%)等并发症相关。甲状腺功能减退患者CD的发生率为18.05%。亚临床甲状腺功能亢进与子痫前期、早产、宫内生长受限、宫内胎儿死亡等并发症相关。结论:妊娠期甲状腺功能障碍与母胎并发症均有显著相关性,对妊娠结局有不利影响。因此,早期识别甲状腺疾病并及时开始治疗是至关重要的
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
47
审稿时长
6 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信